Life Science Investor Day – Part of Emergence 2026 Sydney Wednesday, 18 Feb 2026

Converging Capital with Cures: The Future of Healthcare Investment

We invite you to the Inaugural Life Science Investor Day, the dedicated opening day of Emergence 2026.

Hosted in a landmark strategic partnership between Wholesale Investor and MTPConnect (Australia’s Life Sciences Innovation Accelerator), this exclusive event is the premier platform connecting private capital with the medical technologies, biotechnologies, and pharmaceutical sectors shaping global healthcare.

Why This Day is Different?

While the broader Emergence conference covers the full investment spectrum, February 18th is dedicated exclusively to Life Sciences. This is your opportunity to engage with the innovators solving the world’s most critical health challenges before they hit the mainstream market.

The Theme: Convergence & Abundance in Healthcare

We are witnessing a structural shift where AI, data, and biology converge. This event spotlights how these forces are creating an abundance of opportunities in:

• Biotechnology & Pharma: Breakthrough therapeutics and drug discovery.
• Medical Devices (Medtech): Next-gen diagnostics and surgical innovations.
• Digital Health: AI-driven patient care and remote monitoring.

 What You Will Experience

• Curated Deal Flow: Access up to 30 highly vetted Life Science companies (Private, Small Cap, and Pre-IPO) presenting live.
• Strategic Partnership: This event is co-hosted with MTPConnect, ensuring the highest caliber of industry insight and deal quality.
• Elite Networking: Connect with 500+ attendees including High-Net-Worth Individuals, Family Offices, Venture Capital firms, and institutional fund managers specializing in healthcare.
• Expert Insights: Hear from Keynote Speakers and Panellists discussing the future of Australian Life Sciences, FDA pathways, and global commercialisation strategies.

Who Should Attend?

• Family Offices & HNWIs: Seeking early access to high-growth assets with genuine societal impact.
• Venture Capitalists: Looking for the next “unicorn” in the biotech or medtech space.
• Life Science Fund Managers: Scouting for diverse portfolio additions.
• Pharmaceutical Executives: seeking strategic partnerships and acquisition targets.

Emergence Sydney 2025 Highlights…

About Our Partner

MTPConnect is Australia’s Life Sciences Innovation Accelerator. As a not-for-profit organisation, they champion the growth of Australia’s medical technology, biotechnology, and pharmaceutical sectors. Their partnership with Emergence 2026 ensures that the companies you see are at the cutting edge of Australian innovation.

Interested in Presenting?

PRESENT AT EMERGENCE – Present your company and network with High-Net-Worth, Family Offices and Professional Investors. Register your interest here

Sponsorship Opportunities

PARTNER WITH US – Join us in shaping the Convergence & Abundance at Emergence 2026 by becoming a valued sponsor or partner. Register your interest here

Secure your place at the forefront of medical innovation. Spaces are strictly limited. Early registration is advised to avoid disappointment.

Ticket Options

Standard Investor Ticket

• Full access to all Life Science Investor Day keynotes, panels, and company presentations ( option to get 1 day access only or 3 days full conference access).
• Access to the Exhibition Hall.
• Morning tea, lunch, and afternoon tea provided.
• Access to the standard networking drinks.

VIP Investor Ticket (Recommended) Elevate your experience with exclusivity and comfort.

• Exclusive VIP Dinner: Invitation to the VIP & Speakers Dinner (Strictly limited).
• Front Row Seating: Reserved seating for all keynotes and pitches.
• VIP Lounge Access: A quiet retreat with premium catering, coffee, and networking space throughout the day.
• Private Networking: Access to the VIP Networking Zone to engage with speakers and sponsors.
• Concierge Service: Priority check-in and personalised introductions by our Client Success Team.